Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Foot Injuries and DisordersAnkle Injuries and DisordersAchilles Tendon Injury
Interventions
DRUG

medrol dosepak

"Methylprednisolone is a corticosteroid with anti-inflammatory properties and immune suppression.~This study will utilize a 6-day Medrol Dosepak: a tapered low-dose corticosteroid course taken orally once a day. This includes 6 tablets on day 1 (24 mg), 5 tablets on day 2 (20 mg), 4 tablets on day 3 (16 mg), 3 tablets on day 4 (12 mg), 2 tablets on day 5 (8 mg) and 1 tablet on day 6 (4 mg)."

DRUG

HYDROcodone Oral Tablet

This study will utilize a prescription of 20 pills of hydrocodone, 5mg each, to be taken as needed for pain, 1 every 6 hours.

Trial Locations (2)

30022

RECRUITING

Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center, Johns Creek

30329

RECRUITING

Emory Musculoskeletal Institute, Emory Orthopaedics & Spine Center, Atlanta

All Listed Sponsors
lead

Emory University

OTHER